Fyza Y. Shaikh

683 total citations
17 papers, 488 citations indexed

About

Fyza Y. Shaikh is a scholar working on Molecular Biology, Oncology and Epidemiology. According to data from OpenAlex, Fyza Y. Shaikh has authored 17 papers receiving a total of 488 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 8 papers in Oncology and 4 papers in Epidemiology. Recurrent topics in Fyza Y. Shaikh's work include Cancer Immunotherapy and Biomarkers (7 papers), Gut microbiota and health (6 papers) and Respiratory viral infections research (4 papers). Fyza Y. Shaikh is often cited by papers focused on Cancer Immunotherapy and Biomarkers (7 papers), Gut microbiota and health (6 papers) and Respiratory viral infections research (4 papers). Fyza Y. Shaikh collaborates with scholars based in United States, Canada and Ireland. Fyza Y. Shaikh's co-authors include James E. Crowe, Martin L. Moore, Anne L. Hotard, Cynthia L. Sears, Benjamin Zhu, Aatur D. Singhi, Krishna Patel, Weijing Sun, Changqing Ma and Bing Ren and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Clinical Cancer Research.

In The Last Decade

Fyza Y. Shaikh

17 papers receiving 483 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Fyza Y. Shaikh United States 9 190 157 156 139 123 17 488
David Fuchs Austria 8 78 0.4× 80 0.5× 106 0.7× 124 0.9× 21 0.2× 12 440
Dominic De Groote Belgium 8 81 0.4× 70 0.4× 46 0.3× 92 0.7× 57 0.5× 10 424
Sabrina Nolan United States 12 181 1.0× 32 0.2× 61 0.4× 107 0.8× 21 0.2× 18 489
Akshita Gupta India 8 113 0.6× 34 0.2× 95 0.6× 80 0.6× 21 0.2× 35 294
Katrin Mair Germany 4 39 0.2× 38 0.2× 89 0.6× 246 1.8× 26 0.2× 4 459
Helen Thornton United States 12 97 0.5× 97 0.6× 45 0.3× 71 0.5× 32 0.3× 23 396
Zehui Lei China 11 119 0.6× 25 0.2× 103 0.7× 283 2.0× 50 0.4× 20 478
Frédéric Reynier France 12 76 0.4× 41 0.3× 69 0.4× 150 1.1× 22 0.2× 15 430
Ashley Miller United States 11 41 0.2× 81 0.5× 22 0.1× 67 0.5× 41 0.3× 19 509
Markus Stöcher Austria 13 115 0.6× 54 0.3× 64 0.4× 160 1.2× 15 0.1× 18 429

Countries citing papers authored by Fyza Y. Shaikh

Since Specialization
Citations

This map shows the geographic impact of Fyza Y. Shaikh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fyza Y. Shaikh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fyza Y. Shaikh more than expected).

Fields of papers citing papers by Fyza Y. Shaikh

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fyza Y. Shaikh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fyza Y. Shaikh. The network helps show where Fyza Y. Shaikh may publish in the future.

Co-authorship network of co-authors of Fyza Y. Shaikh

This figure shows the co-authorship network connecting the top 25 collaborators of Fyza Y. Shaikh. A scholar is included among the top collaborators of Fyza Y. Shaikh based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fyza Y. Shaikh. Fyza Y. Shaikh is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Zhao, Yujie, James R. White, Megan D. Schollenberger, et al.. (2025). Gut microbiome features associate with immune checkpoint inhibitor response in individuals with non-melanoma skin cancers: an exploratory study. Microbiology Spectrum. 13(3). e0255924–e0255924. 1 indexed citations
2.
Queen, Jessica, Fyza Y. Shaikh, & Cynthia L. Sears. (2023). Understanding the mechanisms and translational implications of the microbiome for cancer therapy innovation. Nature Cancer. 4(8). 1083–1094. 17 indexed citations
3.
Shaikh, Fyza Y., Joell J. Gills, Fuad Mohammad, et al.. (2022). Murine fecal microbiota transfer models selectively colonize human microbes and reveal transcriptional programs associated with response to neoadjuvant checkpoint inhibitors. Cancer Immunology Immunotherapy. 71(10). 2405–2420. 22 indexed citations
4.
Shaikh, Fyza Y., et al.. (2022). De- “bug”-ing the microbiome in lung cancer. Cancer and Metastasis Reviews. 41(2). 335–346. 5 indexed citations
5.
Wilson, G. W., Jiajia Zhang, Jawara Allen, et al.. (2022). 514. Association Between Antibiotic Exposure and Clinical Outcomes of Immune Checkpoint Inhibition. Open Forum Infectious Diseases. 9(Supplement_2). 1 indexed citations
6.
Kelly, Ronan J., Ali H. Zaidi, Jenna VanLiere Canzoniero, et al.. (2022). Multicenter phase II study of neoadjuvant nivolumab or nivolumab plus relatlimab (anti-LAG3 antibody) plus chemoradiotherapy in stage II/III esophageal/gastroesophageal junction (E/GEJ) carcinoma.. Journal of Clinical Oncology. 40(4_suppl). 321–321. 7 indexed citations
7.
Shaikh, Fyza Y., James R. White, Joell J. Gills, et al.. (2021). A Uniform Computational Approach Improved on Existing Pipelines to Reveal Microbiome Biomarkers of Nonresponse to Immune Checkpoint Inhibitors. Clinical Cancer Research. 27(9). 2571–2583. 27 indexed citations
8.
Shaikh, Fyza Y., Joell J. Gills, & Cynthia L. Sears. (2019). Impact of the microbiome on checkpoint inhibitor treatment in patients with non-small cell lung cancer and melanoma. EBioMedicine. 48. 642–647. 34 indexed citations
9.
Ma, Changqing, Krishna Patel, Fyza Y. Shaikh, et al.. (2016). Frequent programmed death-ligand 1 expression in gastric cancer associated with Epstein-Barr virus or microsatellite instability: Implications for predictive biomarker development.. Journal of Clinical Oncology. 34(15_suppl). e15579–e15579. 1 indexed citations
10.
Patel, Krishna, Fyza Y. Shaikh, Bing Ren, et al.. (2016). Expression of programmed death-ligand 1 (PD-L1), mismatch repair status, and Epstein-Barr status in locally advanced gastric adenocarcinoma: Correlation to clinical outcome.. Journal of Clinical Oncology. 34(15_suppl). e15526–e15526. 1 indexed citations
11.
Ma, Changqing, Krishna Patel, Aatur D. Singhi, et al.. (2016). Programmed Death-Ligand 1 Expression Is Common in Gastric Cancer Associated With Epstein-Barr Virus or Microsatellite Instability. The American Journal of Surgical Pathology. 40(11). 1496–1506. 130 indexed citations
12.
Shaikh, Fyza Y. & Laura W. Goff. (2014). Decoding hepatocellular carcinoma: the promise of microRNAs.. PubMed. 3(2). 93–4. 3 indexed citations
13.
Sapparapu, Gopal, et al.. (2013). Intracellular Neutralization of A Virus Using A Cell-Penetrating Molecular Transporter. Nanomedicine. 9(11). 1613–1624. 7 indexed citations
14.
Hotard, Anne L., Fyza Y. Shaikh, Su Jin Lee, et al.. (2012). A stabilized respiratory syncytial virus reverse genetics system amenable to recombination-mediated mutagenesis. Virology. 434(1). 129–136. 105 indexed citations
15.
16.
Shaikh, Fyza Y. & James E. Crowe. (2012). Molecular Mechanisms Driving Respiratory Syncytial Virus Assembly. Future Microbiology. 8(1). 123–131. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026